|
TMEM201 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.09110498414111E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.6003201248368E-12 |
| Normal-vs-Stage2 |
1.58245999999362E-05 |
| Normal-vs-Stage3 |
1.827740E-04 |
| Normal-vs-Stage4 |
4.033200E-04 |
| Stage1-vs-Stage2 |
9.126000E-01 |
| Stage1-vs-Stage3 |
1.526970E-01 |
| Stage1-vs-Stage4 |
6.948000E-01 |
| Stage2-vs-Stage3 |
2.867600E-01 |
| Stage2-vs-Stage4 |
7.919200E-01 |
| Stage3-vs-Stage4 |
2.984600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.00149888382361E-11 |
| Normal-vs-AfricanAmerican |
2.12590000048252E-07 |
| Normal-vs-Asian |
6.187200E-04 |
| Caucasian-vs-AfricanAmerican |
9.488000E-01 |
| Caucasian-vs-Asian |
2.519000E-01 |
| AfricanAmerican-vs-Asian |
2.014400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.79580000261959E-08 |
| Normal-vs-Female |
7.370200E-04 |
| Male-vs-Female |
1.562250E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.89850000001479E-06 |
| Normal-vs-Extreme_Weight |
6.17760287369151E-11 |
| Normal-vs-Obese |
1.84739999964378E-07 |
| Normal-vs-Extreme_Obese |
2.197600E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.531400E-01 |
| Normal_Weight-vs-Obese |
7.923200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.896600E-01 |
| Extreme_Weight-vs-Obese |
3.566400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.757200E-01 |
| Obese-vs-Extreme_Obese |
8.627200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.177200E-03 |
| Normal-vs-Age(41-60Yrs) |
6.35730001974366E-09 |
| Normal-vs-Age(61-80Yrs) |
6.31209999824023E-08 |
| Normal-vs-Age(81-100Yrs) |
8.77869998916481E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.705400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.229800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.774300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.931820E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.735660E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.228300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.37400000044252E-07 |
| Normal-VS-Type2 PRCC |
3.05229952424213E-10 |
| Normal-VS-KIRP CIMP |
2.278100E-02 |
| Normal-VS-Unclassified PRCC |
7.40409999977487E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.712600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.812240E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.193000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.078820E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.511000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.866800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.28789999460133E-08 |
| Normal-vs-N1 |
2.23870000004567E-06 |
| Normal-vs-N2 |
1.582250E-01 |
| N0-vs-N1 |
9.156400E-01 |
| N0-vs-N2 |
2.307000E-01 |
| N1-vs-N2 |
2.851800E-01 |
|
|
